These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20430036)

  • 1. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin.
    Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G
    J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
    Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
    Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice.
    Schönberger T; Siegel-Axel D; Bussl R; Richter S; Judenhofer MS; Haubner R; Reischl G; Klingel K; Münch G; Seizer P; Pichler BJ; Gawaz M
    Cardiovasc Res; 2008 Oct; 80(1):131-7. PubMed ID: 18566102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice.
    Schönberger T; Ziegler M; Borst O; Konrad I; Nieswandt B; Massberg S; Ochmann C; Jürgens T; Seizer P; Langer H; Münch G; Ungerer M; Preissner KT; Elvers M; Gawaz M
    Am J Physiol Cell Physiol; 2012 Oct; 303(7):C757-66. PubMed ID: 22814400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb.
    Massberg S; Schürzinger K; Lorenz M; Konrad I; Schulz C; Plesnila N; Kennerknecht E; Rudelius M; Sauer S; Braun S; Kremmer E; Emambokus NR; Frampton J; Gawaz M
    Circulation; 2005 Aug; 112(8):1180-8. PubMed ID: 16103235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
    Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivoimaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc.
    Bigalke B; Lindemann S; Schönberger T; Pohlmeyer I; Chiribiri A; Schuster A; Botnar RM; Griessinger CM; Pichler BJ; Gawaz M
    Platelets; 2012; 23(1):1-6. PubMed ID: 21671729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.
    Gawaz M; Konrad I; Hauser AI; Sauer S; Li Z; Wester HJ; Bengel FM; Schwaiger M; Schömig A; Massberg S; Haubner R
    Thromb Haemost; 2005 May; 93(5):910-3. PubMed ID: 15886808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of injured and atherosclerotic arteries in mice using fluorescence-labeled glycoprotein VI-Fc.
    Bigalke B; Pohlmeyer I; Schönberger T; Griessinger CM; Ungerer M; Botnar RM; Pichler BJ; Gawaz M
    Eur J Radiol; 2011 Aug; 79(2):e63-9. PubMed ID: 21497471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.
    Bültmann A; Herdeg C; Li Z; Münch G; Baumgartner C; Langer H; Kremmer E; Geisler T; May A; Ungerer M; Gawaz M
    Thromb Haemost; 2006 May; 95(5):763-6. PubMed ID: 16676064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
    Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
    Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
    Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
    Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
    Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
    Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.